Page last updated: 2024-08-22

diallyl disulfide and Carcinoma, Hepatocellular

diallyl disulfide has been researched along with Carcinoma, Hepatocellular in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Abass, SA; Abdel-Hamid, NM; Abdel-Kareem, MA; Eldomany, RA; Zakaria, S1
Arranz, N; Delgado, ME; GarcĂ­a, A; Haza, AI; Morales, P; Rafter, J1
Chen, X; Li, GC; Shen, L; Wen, J; Xu, M; Zhang, Y1
Aquilano, K; Ciriolo, MR; De Martino, A; Filomeni, G; Rotilio, G1
Belloir, C; Daurat, C; Le Bon, AM; Siess, MH; Singh, V1
Iciek, MB; Rokita, HB; Wlodek, LB1

Other Studies

6 other study(ies) available for diallyl disulfide and Carcinoma, Hepatocellular

ArticleYear
Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats.
    Life sciences, 2022, Apr-01, Volume: 294

    Topics: Alkylating Agents; Allyl Compounds; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Diethylnitrosamine; Disulfides; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Immunosuppressive Agents; Leflunomide; Liver Neoplasms, Experimental; Male; Mitochondrial Dynamics; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-3

2022
Antiapoptotic effects of dietary antioxidants towards N-nitrosopiperidine and N-nitrosodibutylamine-induced apoptosis in HL-60 and HepG2 cells.
    Journal of applied toxicology : JAT, 2009, Volume: 29, Issue:5

    Topics: Allyl Compounds; Antioxidants; Apoptosis; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Culture Techniques; Dietary Supplements; Disulfides; Dose-Response Relationship, Drug; HL-60 Cells; Humans; In Situ Nick-End Labeling; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Nitrosamines; Oxidative Stress; Reactive Oxygen Species

2009
Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells.
    Biochemical pharmacology, 2004, Jul-15, Volume: 68, Issue:2

    Topics: Allyl Compounds; Apoptosis; Carcinoma, Hepatocellular; Disulfides; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Tumor Cells, Cultured

2004
Effects of water garlic extracts on cell cycle and viability of HepG2 hepatoma cells.
    The Journal of nutritional biochemistry, 2006, Volume: 17, Issue:11

    Topics: Allyl Compounds; Biomarkers; Carcinoma, Hepatocellular; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Disulfides; Enzyme Activation; Garlic; Humans; JNK Mitogen-Activated Protein Kinases; Plant Extracts; Selenium; Signal Transduction; Tretinoin; Tumor Suppressor Protein p53; Water

2006
Protective effects of garlic sulfur compounds against DNA damage induced by direct- and indirect-acting genotoxic agents in HepG2 cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2006, Volume: 44, Issue:6

    Topics: Aflatoxin B1; Allyl Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cysteine; Disulfides; DNA Damage; Garlic; Humans; Liver Neoplasms; Mutagens; Sulfhydryl Compounds; Sulfides; Sulfinic Acids; Sulfur Compounds

2006
Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2).
    Neoplasma, 2001, Volume: 48, Issue:4

    Topics: Allyl Compounds; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cystamine; Disulfides; DNA; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Mercaptoethanol; Pyridoxal Phosphate; Thiosulfates; Thymidine; Tumor Cells, Cultured

2001